Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JB062是一种针对非肌肉肌球蛋白(nonmusclemyosin)的抑制剂,其IC50值对骨骼肌肌球蛋白为1.6μM、心肌肌球蛋白为5.4μM,而对平滑肌肌球蛋白II大于100μM。此化合物对人类癌细胞显示出细胞毒性,对正常细胞则无此作用。JB062在肌肉痉挛、慢性肌肉骨骼疼痛及肥厚型心肌病研究中有潜在应用价值。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,300 | 现货 | ||
5 mg | ¥ 3,270 | 现货 | ||
10 mg | ¥ 4,770 | 现货 | ||
25 mg | ¥ 7,530 | 现货 | ||
50 mg | ¥ 9,870 | 现货 | ||
100 mg | ¥ 13,600 | 现货 | ||
500 mg | ¥ 27,300 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,110 | 现货 |
产品描述 | JB062 is a chemical compound acting as a nonmuscle myosin inhibitor, exhibiting IC50 values of 1.6, 5.4, and >100 μM against skeletal muscle myosin, cardiac muscle myosin, and smooth muscle myosin II, respectively. It selectively exhibits cytotoxicity towards human cancer cells without affecting normal cells. The compound is applicable in research fields concerning muscle spasticity, chronic musculoskeletal pain, and hypertrophic cardiomyopathy. |
靶点活性 | Cardiac muscle myosin:5.4 μM, Smooth muscle myosin II:>100 μM, Skeletal muscle myosin:1.6 μM |
体外活性 |
JB062 (40 μM ; 24 h) inhibited cytoplasmic division in COS-7 cells.[1] JB062 (COS-7 cells) exhibited cytotoxicity against human cancer cells but showed no cytotoxicity towards normal cells, with an IC50 value of 36 μM.[1] |
分子量 | 323.34 |
分子式 | C19H17NO4 |
CAS No. | 2417988-00-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (69.58 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.0927 mL | 15.4636 mL | 30.9272 mL | 77.318 mL |
5 mM | 0.6185 mL | 3.0927 mL | 6.1854 mL | 15.4636 mL | |
10 mM | 0.3093 mL | 1.5464 mL | 3.0927 mL | 7.7318 mL | |
20 mM | 0.1546 mL | 0.7732 mL | 1.5464 mL | 3.8659 mL | |
50 mM | 0.0619 mL | 0.3093 mL | 0.6185 mL | 1.5464 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
JB062 2417988-00-0 Cytoskeletal Signaling Myosin Inhibitor inhibitor inhibit